Guardant Health (GH) Revenue (2017 - 2026)

Guardant Health has disclosed Revenue across 10 years of filings, most recently posting $301.7 million for Q1 2026.

• Revenue for Q1 2026 came in at $301.7 million, up 48.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 billion (up 39.56% YoY), and the FY2025 annual result was $982.0 million, up 32.88% from the prior year.
• Revenue came in at $301.7 million for Q1 2026 at Guardant Health, up from $281.3 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $301.7 million in Q1 2026 to a low of $96.1 million in Q1 2022.
• The 5-year median for Revenue is $168.5 million (2024), against an average of $178.6 million.
• Across the five-year window, Revenue grew 17.37% in 2022 and surged 48.26% in 2026, its largest moves.
• Guardant Health's Revenue stood at $126.9 million in 2022, then gained by 22.19% to $155.1 million in 2023, then surged by 30.16% to $201.8 million in 2024, then jumped by 39.37% to $281.3 million in 2025, then increased by 7.25% to $301.7 million in 2026.
• The last three Revenue figures came in at $301.7 million (Q1 2026), $281.3 million (Q4 2025), and $265.2 million (Q3 2025), per Business Quant data.